Menu
Sector
Investment stage
Source
Therapeutics
Investment amount
£25.5m
Investment share
14.0%
Source
Imperial College London
Investment stage
Listed

A clinical-stage specialty biopharmaceutical company developing a range ...

Find out more
Engineering & Materials
Investment amount
£22.4m
Investment share
38.0%
Source
Imperial College London
Investment stage
post-Series A

Unique silicon anodes for next generation Lithium-ion batteries ...

Find out more
Medtech
Investment amount
£9.8m
Investment share
44.3%
Source
Imperial College London
Investment stage
post-Series A

3D stent technology intended to improve the biomechanical ...

Find out more
Therapeutics
Investment amount
£10.5m
Investment share
26.2%
Source
Imperial College London
Investment stage
post-Series A

Services and technologies to enable the development of ...

Find out more
Medtech
Investment amount
£6.0m
Investment share
4.8%
Source
University of Oxford
Investment stage
Listed

Novel diagnostic tests based on T-cell measurement technology

Find out more
Therapeutics
Investment amount
£4.8m
Investment share
30.0%
Source
Imperial College London
Investment stage
post-Series A

Developing cell based products for immune reconstitution and ...

Find out more
Therapeutics
Investment amount
£7.5m
Investment share
29.9%
Source
University of Oxford
Investment stage
post-Series A

Innovative therapeutics for serious diseases with a particular ...

Find out more
Engineering & Materials
Investment amount
£6.0m
Investment share
44.0%
Source
Imperial College London
Investment stage
post-Series A

Focused on the production of next generation biopolymers ...

Find out more
Medtech
Investment amount
£5.0m
Investment share
16.0%
Source
University College London
Investment stage
post-Series A

Innovative orthopaedic business focused on patient specific primary ...

Find out more
Engineering & Materials
Investment amount
£4.4m
Investment share
53.6%
Source
Imperial College London
Investment stage
post-Series A

Copolymerisation catalysts that blend CO2 with epoxides, producing ...

Find out more
Therapeutics
Investment amount
£5.0m
Investment share
31.0%
Source
University College London
Investment stage
post-Series A

Pioneering the development of novel therapeutics for the ...

Find out more
Therapeutics
Investment amount
£5.9m
Investment share
33.4%
Source
Imperial College London
Investment stage
post-Series A

Developing novel small molecule medicines as topical treatments ...

Find out more
ICT/Digital
Investment amount
£4.0m
Investment share
30.6%
Source
Imperial College London
Investment stage
post-Series A

Developing bio-inspired vision system enabling intelligent image recognition

Find out more
Engineering & Materials
Investment amount
£3.3m
Investment share
34.1%
Source
Imperial College London
Investment stage
post-Series A

Axial Flux motors and generators for automotive and ...

Find out more
Therapeutics
Investment amount
£3.3m
Investment share
18.4%
Source
Babraham Institute
Investment stage
post-Series A

Differentiated medicines through unique transgenic antibody fragment platform

Find out more
Therapeutics
Investment amount
£2.8m
Investment share
20.0%
Source
University of Cambridge
Investment stage
post-Series A

Cancer therapeutics based on new understandings of DNA ...

Find out more
Medtech
Investment amount
£4.8m
Investment share
36.4%
Source
Imperial College London

Developer and distributer of state-of-the-art diagnostic tools and ...

Find out more
ICT/Digital
Investment amount
0
Investment share
23.3%
Source
Imperial College London
Investment stage
IP Equity

Leading supplier of advanced process modeling software & ...

Find out more
Therapeutics
Investment amount
£1.8m
Investment share
17.6%
Source
Imperial College London
Investment stage
post-Series A

Generating anti-infective agents to treat RSV & Aspergillus

Find out more
ICT/Digital
Investment amount
£1.5m
Source
Imperial College London

Social media analytics for entertainment marketing

Find out more
Medtech
Investment share
18.0%
Source
Imperial College London

Medical imaging services and rapid diagnostics

Find out more
ICT/Digital
Investment amount
£2.4m
Investment share
22.0%
Source
University of Cambridge

Leading predictive analytics company

Find out more
Engineering & Materials
Investment amount
0
Investment share
26.0%
Source
Imperial College London

Experts in remote monitoring solutions for the oil ...

Find out more
Engineering & Materials
Investment amount
0.6
Source
University of Oxford

Developing enzymatic process technologies that yield high value ...

Find out more
Medtech
Investment amount
0.5
Investment share
20.9%
Source
University of Cambridge

Live, online cognitive behavioural therapy

Find out more
Engineering & Materials
Investment amount
0.3m
Source
University of Cambridge

Developing unique solutions for encapsulation based on cutting-edge ...

Find out more
ICT/Digital
Investment amount
2.3m
Investment share
30.0%
Source
Imperial College London

Mobile payments with integrated loyalty schemes

Find out more